You are here

SIOG is proud to announce its 1st SIOG LATAM joint session in collaboration with the Brazilian Society of Clinical Oncology during the 1st Brazilian Oncology Week in Rio de Janeiro, Brazil from October 25-28. This event is jointly organized by the Brazilian Medical Oncology Society, the Brazilian Surgical Oncology Society as well as the Brazilian Radiation Oncology Society. These sessions have received the support of the Brazilian Society of Geriatrics (SBGG).

Two half-day sessions will take place on October 26 and October 27, 2017 and will be fully dedicated to Geriatric Oncology. These sessions will feature well renown SIOG speakers as well as their Brazilian counterparts. The goal of these sessions is to provide the congress delegates with an introduction to geriatric oncology which is about how should oncologists be individualizing their treatment approach based on the risks and benefits of therapy, what instruments can help oncologists to have a better view of the patient’s overall health situation as well as how does the cancer and the cancer treatment impact the aging process of the patient.

The official conference language is Portuguese and simultaneous interpretation will be provided for this session.

More information about the 1st Brazilian Oncology Week.
To view the full Scientific programme, click here.

Venue

Windsor Oceânico
R. Martinho de Mesquita, 129 - Barra da Tijuca, Rio de Janeiro - RJ, 22620-220
Tel: +55 21 2195-9950
Website

Download

PDF iconSBOC SIOG LATAM 2017 scientific programme.pdf

Contact

You are interested in attending this session only, please contact: Theodora Karnakis at theokarnakis@yahoo.com.br

We are looking forward to seeing you in Rio!

DAY 1 - Thursday, October 26, 2017 - Sala 09

14:00-14:30 Welcome

Chairs: Stuart Lichtman (US) and Theodora Karnakis (BR)
14:00-14:10 Welcome from SBOC - Gustavo Fernandes (BR)
14:10-14:20 SIOG welcome and overview of projects 2017-2018 - Stuart Lichtman (US)
14:20-14:30 How is Geriatric Oncology perceived in Brazil? A national survey - Theodora Karnakis (BR)

14:30-16:00 The relevance of Geriatric Oncology

Chairs: Matti Aapro (CH) and Rafael Kaliks (BR)
14:30-14:45 Current scenario of aging and cancer in worldwide and in Latin America - Ludmila Koch (BR)
14:45-15:00 Geriatric oncology: is it standard of care or merely for clinical research? - Enrique Soto Perez de Celis (US/MX)
15:00-15:15 Economic challenges of cancer treatment, also in the elderly - Matti Aapro (CH)
15:15-15:30 Challenges in the implementation of a multidisciplinary team in Geriatric Oncology - Theodora Karnakis (BR)
15:30 -16:00 General discussion and questions - Moderated by Rafael Kaliks (BR)

16:00-16:30 Coffee break, poster viewing & exhibition

16:30-18:00 Adapting treatment to complex cases: lessons from Geriatric Oncology

Chairs: Riccardo Audisio (GB) and Felipe Coimbra (BR)
16:20-16:35 Choice of chemotherapy and assessment of toxicity - Stuart Lichtman (US)
16:35-16:50 Polypharmacy: the risks of drug interaction - Rachel Riechelmann (BR)
16:50-17:05 Pre-and post-surgical care of the patient - Riccardo Audisio (GB)
17:05-17:20 Surgical particularities in elderly cancer patients - Benedito Rossi (BR)
17:20-17:35  Considerations of Radiation therapy  in elderly patients - Harley Oliveira (BR)
17:35-18:00 General discussion and questions - Moderatad by Felipe Coimbra (BR)

 

DAY 2 - Friday, October 26, 2017 - Sala 09

14:00-15:00 Research and education in Geriatric Oncology

Chairs: Enrique Soto Perez de Celis (US/MX) and Rachel Riechelmann (BR)
14:00-14:15 What do we know about the biology of aging and cancer? - Etienne Brain (FR)
14:15-14:30 What is the challenge of innovation in elderly? - Enrique Soto Perez de Celis (US/MX)
14:30-14:45 How to train and educate professionals in Geriatric Oncology - Etienne Brain (FR)
14:45-15:00 General discussion and questions - Moderated by Rachel Riechelmann (BR)

15:00-16:00 Using geriatric assessment and screening test: when and how?

Chairs: Etienne Brain (FR) and Roberto Lourenço (BR)
15:00-15:15 The best model to evaluate geriatric oncology patients: there is it? - Stuart Lichtman (US)
15:15-15:30 Using screening test to define who should or not receive full Geriatric Oncology Assessment (CGA) - Jurema Telles (BR)
15:30-15:45 Defining frailty to define the best choice in geriatric oncology treatment - Eduardo Ferrioli (BR)
15:45-16:00 General discussion and questions - Moderated by Roberto Lourenço (BR)

16:00-16:30 Coffee break, poster viewing & exhibition

16:30-18:00 Hot topics

Chairs: Frederico Teixeira (BR) and Stuart Lichtman (US)
16:30-16:45 Overview of recent SIOG guidelines - Etienne Brain (FR)
16:45-17:00 New techniques in oncology surgery - Andre Godoy (BR)
17:00-17:15 Targeted immunotherapies in the elderly - Matti Aapro (CH)
17:15-17:30 Genetic syndromes in the elderly: when to suspect? - Bernardo Garicochea (BR)
17:30-17:50 Supportive care impact on patient survival - Matti Aapro (CH)
17:50-18:00 General discussion and questions - Moderated by Rafael Kaliks (BR)